SENATE 3220118th CongressRead twice and referred to the Committee on Health, Education, Labor, and Pensions.
A bill to expand the tropical disease product priority review voucher program to encourage prevention and treatment of coccidioidomycosis.
- Last Action
- 11/2/2023
Actions
- 2023-11-02Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- 2023-11-02Introduced in Senate
CRS Summary
As of 2023-11-02 (00)
This bill expands the priority-review voucher program for tropical diseases to include coccidioidomycosis (also known as Valley fever). A voucher entitles the holder to have a future new drug or biological product application acted upon by the Food and Drug Administration within six months.
Cosponsors (4)
- Kyrsten Sinema (I-AZ)
- Markwayne Mullin (R-OK)
- John Hickenlooper (D-CO)
- Jeff Merkley (D-OR)
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.